Director Declaration

RNS Number : 5979T

e-Therapeutics plc

09 June 2009

 



e-Therapeutics plc

('ETX' or 'the Company')

CHANGE TO DIRECTOR'S DETAILS

Pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies, Dr Royston Drucker (Chief Medical Officer of the Company) has become aware that  Technomark Consulting Services Limited, a company of which he was a non-executive director until his resignation on 08 June 2007, entered a company voluntary arrangement on 17 March 2008. 

Dr Royston Drucker has no further details at this time.

For further information please contact:

e-Therapeutics plc	www.etherapeutics.co.uk
Malcolm Young	[phone]
Nominated Adviser
WH Ireland Limited	[phone]
Katy Mitchell
Broker
Cornhill Asset Management	[phone]
Tom Whitehead
Media enquiries
Abchurch
Heather Salmond	[phone]
Stephanie Cuthbert	[phone]
Simone Alves	[phone]

 

END

 

 

RDNUUUPWQUPBGUB